Health Data Research UK (HDR UK)
HDR UK Cambridge aims to realise novel insights into biology and disease aetiology through integration of information, at scale, on genomics, other biomolecular traits, and high-resolution electronic health records (EHRs)
Teamwork is key – we will share the knowledge we generate through this research with existing major national initiatives which are contemplating or conducting related work. This may include UK Biobank, the 100,000 Genomes Project, NIHR BioResource, Deciphering Development Disorders and the nascent Genomic Medicine Service.
There is major potential to realise novel insights from such bioresources by combining, at scale, innovative bioassays, assessment of other intermediate phenotypes, and linkages with EHRs, and by working across these cohorts to achieve even greater scale, synergy and contrast. A key concept is the increasing ability to anchor inference about the causes of
diseases in genomic data from cohorts of populations and patents. This inference involves integrative analyses (e.g., Mendelian randomisation approaches) that can help reveal the temporality and direction of causal effects across layers of biodata, extending from genomes to dynamic high-dimensional traits (e.g. proteins and other components of the “expressed genome”) to organ structure to EHRs. The results from such analyses have the potential to help underpin a shift from disease classification based on pattern of end-organ injury to one based on molecular underpinnings.
Genomics of inflammation and immunity
The goal of our research is to use high-throughput screens to gain causal insights into the biological basis of human disease, ...
Health Data Research UK Cambridge Hub
The Danesh group works as part of the Health Data Research (HDR) UK Cambridge site, using genomic, molecular and electronic ...
Genomic mutation and genetic disease
The Hurles group studies the genetic causes and mechanisms of rare genetic disorders and how DNA mutates as it is pass ...
Deciphering Developmental Disorders (DDD)
The aim of the Deciphering Developmental Disorders (DDD) Study is to advance clinical genetic practice for children with developmental disorders by ...
Genomics England is a company wholly owned by the UK government, tasked with delivering genomic medicine in partnership with the NHS. ...
Health Data Research UK
Health Data Research UK (HDR-UK) is the national institute for health data science. HDR-UK is uniting the UK’s health data ...
Related news and blogs
27 Oct 2022
Wellcome Sanger Institute announces three inaugural Excellence Fellows
The first three Sanger Excellence Postdoctoral Fellows have been announced and will join the Wellcome Sanger Institute in the coming months, ...
11 May 2022
Increased mutations in children can be traced back to mistakes in father’s sperm
Researchers have traced the cause of increased numbers of mutations in children to a higher rate of random mutations in sperm ...